Overview / Abstract: |
Target Audience This educational activity is directed primarily toward endocrinologists, rheumatologists, nephrologists, pediatricians, primary care providers, geneticists, nurse practitioners, and physician assistants. The secondary target audience includes pharmacists, managed care professionals, neurologists, orthopedists, radiologists, fellows and other health care professionals involved in the care of patients with XLH or TIO. Activity Overview As chronic diseases, X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) have a debilitating impact on the quality of life of affected patients. In XLH, significant complications result from unresolved symptoms in childhood, as well as from disease progression. In TIO, difficulties locating or resecting the causative tumor can result in lifelong morbidity. Unfortunately, knowledge of these conditions is also limited, and many patients experience delayed diagnoses and ineffective treatment. This activity provides clinicians with a deeper understanding of XLH and TIO in terms of the pathophysiology and clinical presentation so they can better manage patients. In this activity, the faculty describe available novel therapies and their unique mechanisms in order to better select treatments for patients. They also explain the mechanism of action of novel therapies for XLH and TIO. In addition, a white board animation helps to illustrate this for participants. Learning Objectives Upon successful completion of this activity, you should be better prepared to: Describe the pathophysiological basis for the development of symptoms in patients with XLH or TIO |
Expiration |
Jan 20, 2022 |
Discipline(s) |
Nursing CNE, Physician CME |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty FACULTY_NAME FACULTY_NAME |
Sponsors / Supporters / Grant Providers |
Ultragenyx Pharmaceutical Inc. |
Keywords / Search Terms |
Relias LLC Relias LLC., FREE CME., XLH ,TIO Free CE CME |